Company / PP&E (Net)
Avanos Medical, Inc. PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$113.4M
FY2025
5-year range
$110.7M / $168.1M
FY2021-FY2025
Trend
+2.4%
vs FY2024
Sector context
#81 of 135
Health Care
What the data says
At $113M, Avanos Medical, Inc.'s pp&e (net) ranks #81 of 135 in the Health Care sector. PP&E (Net) returned to growth in FY2025 after 5 years of decline, reaching $113M.
Based on SEC 10-K filings.
$113M in FY2025 with a 5-year CAGR of -8.3%.
Declined from $117M to $113M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -1.5%
- 5-Year CAGR
- -8.3%
- 10-Year CAGR
- -
Sector benchmark
#81 of 135 in Health CareTop 60% of 135This company $113.4M Sector average $1.4B
▼
-91.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -8.3%, indicating a declining trend.
- In FY2025, pp&e (net) increased 2.4% year-over-year.
- Ranks #81 out of 135 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $113.4M | +2.4% |
| FY2024 | $110.7M | -5.5% |
| FY2023 | $117.2M | -1.2% |
| FY2022 | $118.6M | -29.4% |
| FY2021 | $168.1M | -4.1% |
| FY2020 | $175.3M | -5.0% |
| FY2019 | $184.5M | +19.7% |
| FY2018 | $154.1M | +40.2% |
| FY2017 | $109.9M | +0.5% |
| FY2016 | $109.3M | -60.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026